YUAN Cong
Department of Cardiology, the First Hospital of Changsha, Changsha, Hunan 410000, China;Institute of Cardiovascular Disease, University of South China & Key Laboratory for Arteriosclerology of Hunan Province & International Joint Laboratory for Arteriosclerotic Disease Research of Hunan Province, Hengyang, Hunan 421001, China;Health Management Center/Cadre Health Department, the First Hospital of Changsha, Changsha, Hunan 410000, ChinaXIE Nan
Department of Cardiology, the First Hospital of Changsha, Changsha, Hunan 410000, ChinaREN Zhong
Institute of Cardiovascular Disease, University of South China & Key Laboratory for Arteriosclerology of Hunan Province & International Joint Laboratory for Arteriosclerotic Disease Research of Hunan Province, Hengyang, Hunan 421001, ChinaWU Jie
Department of Cardiology, the First Affiliated Hospital of University of South China, Hengyang, Hunan 421001, ChinaJIANG Zhisheng
Institute of Cardiovascular Disease, University of South China & Key Laboratory for Arteriosclerology of Hunan Province & International Joint Laboratory for Arteriosclerotic Disease Research of Hunan Province, Hengyang, Hunan 421001, China1.Department of Cardiology, the First Hospital of Changsha, Changsha, Hunan 410000, China;2.Institute of Cardiovascular Disease, University of South China & Key Laboratory for Arteriosclerology of Hunan Province & International Joint Laboratory for Arteriosclerotic Disease Research of Hunan Province, Hengyang, Hunan 421001, China;3.Health Management Center/Cadre Health Department, the First Hospital of Changsha, Changsha, Hunan 410000, China;4.Department of Cardiology, the First Affiliated Hospital of University of South China, Hengyang, Hunan 421001, China)
R363;R5
YUAN Cong, XIE Nan, REN Zhong, WU Jie, JIANG Zhisheng. The antagonist role of H2S against senescence of HUVEC may involve activation of SIRT1 S-sulfhydrylation and reduction of FOXO1 acetylation[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2023,31(9):746-753.
Copy